Skip to search formSkip to main contentSkip to account menu

Uterine Carcinosarcoma

Known as: mixed Mullerian sarcoma, uterine, carcinosarcoma uterus, Uterine Malignant Mixed Mesodermal (Müllerian) Tumor 
A usually aggressive malignant neoplasm arising from the uterine corpus and less often the cervix. It is characterized by the presence of two… 
National Institutes of Health

Related topics

Related topics

13 relations
Body tissueEpithelial CellsEpitheliumFemale Reproductive System

Narrower (1)

Uterine Corpus Carcinosarcoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
An Update on the Management of Uterine Carcinosarcoma
Carcinosarcomas are rare aggressive neoplasms with a poor prognosis. The recent International Federation of Gynecology and… 
Review
2011
Review
2011
The influence of adjuvant radiotherapy on patterns of failure and survivals in uterine carcinosarcoma
Purpose To evaluate the impact of postoperative radiotherapy (PORT) on patterns of failure and survivals in uterine… 
2010
2010
Prediction of Chemotherapy Response With Platinum and Taxane in the Advanced Stage of Ovarian and Uterine Carcinosarcoma: A Clinical Implication of In vitro Drug Resistance Assay
Objectives:To evaluate the role of an in vitro drug resistance assay to predict the response to platinum and taxane combination… 
2008
2008
Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution.
2006
2006
Uterine Carcinosarcoma Arising From an Endometrial Polyp
Uterine carcinosarcomas are uncommon malignant tumors, characterized histologically by the presence of both malignant glandular… 
Review
2004
Review
2004
Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus.
Review
2001
Review
2001
Adjuvant pelvic radiotherapy for uterine carcinosarcoma in a high risk population.
OBJECTIVES The purpose of this study was to examine the clinical outcomes of patients with uterine carcinosarcoma and to review… 
2001
2001
K-ras exon 2 point mutations in human endometrial cancer.
2000
2000
TNP-470 inhibits growth and the production of vascular endothelial growth factor of uterine carcinosarcoma cells in vitro.
BACKGROUND Carcinosarcoma is the most aggressive neoplasm among the known uterine malignancies. Most patients who are affected… 
Highly Cited
1997
Highly Cited
1997
Uterine carcinosarcoma in association with tamoxifen therapy
The patients were 73 and 90 year old postmenopausal women who had right total mastectomies in 1988 and 1994 (cases 1 and 2… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)